A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Clinical trial NCT06476808 · RECRUITING

Trial details

NCT number: NCT06476808
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High-grade Serous Ovarian Carcinoma (HGSOC)Uterine Serous Carcinoma (USC)Non-small Cell Lung Cancer (NSCLC)

Start date: 2024-09-06
Primary completion: 2028-12-19
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.